5-Iodo-6-methyluracil is a halogenated derivative of uracil, a pyrimidine nucleobase. This compound features an iodine atom at the 5-position and a methyl group at the 6-position of the uracil ring, which contributes to its unique chemical properties. It is typically characterized by its solid state at room temperature and exhibits moderate solubility in polar solvents. The presence of the iodine atom can influence its reactivity, making it a potential candidate for various chemical reactions, including nucleophilic substitutions. Additionally, 5-iodo-6-methyluracil may exhibit biological activity, particularly in the context of nucleic acid metabolism and potential therapeutic applications. Its structure allows for interactions with enzymes and other biomolecules, which can be of interest in medicinal chemistry. As with many halogenated compounds, care should be taken regarding its handling and disposal due to potential environmental and health impacts. Overall, 5-iodo-6-methyluracil serves as an important compound in both synthetic and biological chemistry contexts.

5-iodo-6-methyluracil

1461-67-2: 5-iodo-6-methylpyrimidine-2,4(1H,3H)-dione

2,4(1H,3H)-Pyrimidinedione, 5-iodo-6-methyl-

5-Iodo-6-methyluracil is a molecule that has been used in the study of transcriptional regulation. It was shown to inhibit skin tumor formation and skin cancer, as well as HIV infection in vitro. The mechanism of action for 5-Iodo-6-methyluracil is not yet clear, but it may be due to its ability to inhibit the polymerase chain reaction (PCR) or to induce apoptosis through various mechanisms. This molecule also has been used in cell lysis experiments on leukemia inhibitory factor and carcinoma cell lines. The structural analysis of this molecule has been accomplished using plasma mass spectrometry.

CAS 1461-67-2: 5-iodo-6-methyluracil

2,4(1H,3H)-Pyrimidinedione, 5-iodo-6-methyl-

Ref: IN-DA001DOR

5-Iodo-6-methyluracil

Ref: 3D-BAA46167

5-IODO-6-METHYL-1H-PYRIMIDINE-2,4-DIONE

Ref: 10-F303169